Home › All Companies › ADGM › Annual Report

Adagio Medical Holdings, Inc. (ADGM) — Annual Report

AI-Powered SEC Filing Analysis

← All ADGM filings
Latest Annual Report Filed: 2026-03-27

Key Insights

  • Adagio Medical Holdings, Inc. (ADGM) reported significant increases in intangible asset impairment charges and convertible securities/warrants over the past 3 years, indicating potential financial and operational challenges.
  • The company has relied heavily on related party transactions with Fjord Ventures for shared services and office/manufacturing space, raising concerns about conflicts of interest and financial dependence.
  • Adagio Medical has implemented several new equity incentive plans over the past few years, suggesting potential dilution for common shareholders.
Sentiment: Negative Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-27. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Adagio Medical Holdings, Inc.

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.